GIOVANNONI, ROBERTO
GIOVANNONI, ROBERTO
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
2019 C.R. Sirtori, M. Ruscica, L. Calabresi, G. Chiesa, R. Giovannoni, J.L. Badimon
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
2019 F. Giordano, V. Vaira, D. Cortinovis, S. Bonomo, J. Goedmakers, F. Brena, A. Cialdella, L. Ianzano, I. Forno, M.G. Cerrito, R. Giovannoni, G.L. Ferri, E. Tasciotti, S. Vicent, F. Damarco, S. Bosari, M. Lavitrano, E. Grassilli
Microarray analysis of liver gene expression in Apoa-I Milano knock-in mouse models
2018 C. Parolini, R. Brambilla, G.S. Ganzetti, E. Rigamonti, R. Giovannoni
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| HDL therapy today: from atherosclerosis, to stent compatibility to heart failure | 2019 | Sirtori, C RRuscica, MCalabresi, LChiesa, GGiovannoni, R + | Article (author) | - | |
| p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma | 2019 | Vaira V.Cortinovis D.Bonomo S.Forno I.Giovannoni R.Damarco F.Bosari S. + | Article (author) | - | |
| Microarray analysis of liver gene expression in Apoa-I Milano knock-in mouse models | 2018 | C. ParoliniG. S. GanzettiE. RigamontiR. Giovannoni + | Article (author) | - |